TP53 and breast cancer: Thus, Wallenstein and coworkers, through the analysis of 16 different genetically mouse models for breast cancer, provided evidence that the loss of p53 in cancer cells induced the secretion of WNT ligands that stimulate tumor-associated macrophages to produce interleukin-1β, thus inducing a condition of systemic inflammation [424].